Insulin glargine
Improve glycemic control in adult patients with diabetes mellitus, Improve glycemic control in pediatric patients with diabetes mellitus
High-alert medication
- Insulin, subcutaneous and IV (class)
Indications
- Improve glycemic control in adult patients with diabetes mellitus
- Improve glycemic control in pediatric patients with diabetes mellitus
Adult dosing
- type 2 dm initiation: dose: 0.2; unit: units/kg; route: SC; interval: once daily, or up to 10 units; weightBased: true; maxDose: 10; maxDoseAbsolute: true; labelExcerpt: The recommended starting dosage of LANTUS in patients with type 2 diabetes who are not currently treated with insulin is 0.2 units/kg or up to 10 units once daily.
Pediatric dosing
- Consult pharmacy/current label
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- Frequent glucose monitoring and dosage adjustment may be necessary.
Contraindications
- Hypoglycemia
- Hypersensitivity to insulin glargine
Clinical pearls
- Do not administer intravenously or via an insulin pump.
- Rotate injection sites to reduce risk of lipodystrophy.
- Monitor blood glucose more frequently when changing insulin regimens.
- Never share pens, syringes, or needles between patients.
Source and review
- DailyMed label (insulin glargine, Lantus Solostar), Set ID d5e07a0c-7e14-4756-9152-9fea485d654a, effective 2025-06-02. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties